The short version of somatotroph fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-05 and is reviewed periodically as new material appears.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
=== iDP === Internal DisplayPort (iDP) is a standard that defines an internal link between a digital TV system on a chip controller and the display panel's timing controller. Version 1.0 was approved in April 2010. It aims to replace currently used internal FPD-Link lanes with a DisplayPort connection. iDP features a unique physical interface and protocols, which are not directly compatible with DisplayPort and are not applicable to external connection, however they enable very high resolution and refresh rates while providing simplicity and extensibility. iDP features a non-variable 2.7 GHz clock and is nominally rated at 3.24 Gbit/s per lane, with up to sixteen lanes in a bank, resulting in a six-fold decrease in wiring requirements over FPD-Link for a 1080p24 signal; other data rates are also possible. iDP was built with simplicity in mind so doesn't have an AUX channel, content protection, or multiple streams; it does however have frame sequential and line interleaved stereo 3D.
Protamine sulfate is a medication that is used to reverse the effects of heparin. It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and heart surgery. It is given by injection into a vein. The onset of effects is typically within five minutes. Common side effects include low blood pressure, slow heart rate, allergic reactions, and vomiting. Allergic reactions may be severe and include anaphylaxis. The risk is greater in males who have had a vasectomy. While there is no evidence of harm from use during pregnancy it has not been well studied in this group. Protamine works by binding with heparin. Protamine sulfate was approved for medical use in the United States in 1969. It is on the World Health Organization's List of Essential Medicines. It was originally made from the sperm of salmon (salmine, salmon protamine). It is now mainly made using recombinant biotechnology.
== Synthetic biomolecular condensates == Biomolecular condensates can be synthesized for a number of purposes. Synthetic biomolecular condensates are inspired by endogenous biomolecular condensates, such as nucleoli, P bodies, and stress granules, which are essential to normal cellular organization and function. Synthetic condensates are an important tool in synthetic biology, and have a wide and growing range of applications. Engineered synthetic condensates allow for probing cellular organization, regulating cellular physiology, facilitating metabolic pathways, and enable the creation of novel functionalized biological materials, which have the potential to serve as drug delivery platforms and therapeutic agents.
== Uses and Impact == Labour was induced or stimulated after random allocation of the mothers to one of three oxytocics (prostaglandin E2 orally, oxytocin intravenously, or demoxytocin buccally).Using as models, the neurohypophyseal nonapeptide hormone oxytocin and its analogue deaminooxytocin, several directed routes to formation of sulfur-sulfur bridges have been developed and evaluated. PGE2 tablets (Prostin) were given to 109 parturients and demoxytocin resoriblets (Sandopart) to 84. Use of oral oxytocics for stimulation of labor in cases of premature rupture of the membranes at term. A randomized comparative study of prostaglandin E2 tablets and demoxytocin resoriblets. The efficacy of oral PGE2 tablets and buccal demoxytocin (resoriblets) for the induction of labor in cases of premature rupture of the membranes (PROM) after the 37th week of gestation has been evaluated in a prospective, randomized investigation of 193 women.
== General references == Acheson, D. J. (1990), Elementary Fluid Dynamics, Oxford Applied Mathematics and Computing Science Series, Oxford University Press, ISBN 978-0-19-859679-0 Batchelor, G. K. (1967), An Introduction to Fluid Dynamics, Cambridge University Press, ISBN 978-0-521-66396-0 Currie, I. G. (1974), Fundamental Mechanics of Fluids, McGraw-Hill, ISBN 978-0-07-015000-3 V. Girault and P. A. Raviart. Finite Element Methods for Navier–Stokes Equations: Theory and Algorithms. Springer Series in Computational Mathematics. Springer-Verlag, 1986 Landau, L. D.; Lifshitz, E. M. (1987), Fluid mechanics, vol. Course of Theoretical Physics Volume 6 (2nd revised ed.), Pergamon Press, ISBN 978-0-08-033932-0, OCLC 15017127 Polyanin, A. D.; Kutepov, A. M.; Vyazmin, A. V.; Kazenin, D. A. (2002), Hydrodynamics, Mass and Heat Transfer in Chemical Engineering, Taylor & Francis, London, ISBN 978-0-415-27237-7 Rhyming, Inge L. (1991), Dynamique des fluides, Presses polytechniques et universitaires romandes Smits, Alexander J. (2014), A Physical Introduction to Fluid Mechanics, Wiley, ISBN 0-47-1253499 Temam, Roger (1984): Navier–Stokes Equations: Theory and Numerical Analysis, ACM Chelsea Publishing, ISBN 978-0-8218-2737-6 Milne-Thomson, L.M., C.B.E (1962), Theoretical Hydrodynamics, Macmillan & Company Limited Tartar, L (2006), An Introduction to Navier Stokes Equation and Oceanography, Springer ISBN 3-540-35743-2 Birkhoff, Garrett (1960), Hydrodynamics, Princeton University Press Campos, D.
Sources: en.wikipedia.org
On 3 January 2026, the United States launched a military intervention in Venezuela and captured Venezuelan president Nicolás Maduro and his wife, Cilia Flores, leading to reactions from across the world. Several governments condemned the intervention, with some describing them as a violation of international law, while others expressed support, vague apprehension or were noncommittal. Most condemnations for the strikes came from countries in Africa, Asia, and most of Latin America, whereas most countries in Europe and North America, particularly NATO member states, supported the airstrikes on Venezuela and capture of Maduro.
=== Characteristics === Of all common cockroach species, the American cockroach has the largest body size, and has the longest life cycle, up to about 700 days. It molts 6–14 times (mostly 13 times) before metamorphosis. It has an average length around 4 cm (1.6 in) and is about 7 mm (0.28 in) tall. They are reddish brown and have a yellowish margin on the pronotum, the body region behind the head. Immature cockroaches resemble adults, except that they are wingless. The insect can travel quickly, often darting out of sight when a threat is perceived, and can fit into small cracks and under doors despite its fairly large size. It is considered one of the fastest-running insects. In an experiment, a P. americana registered a record speed of 5.4 km/h (3.4 mph), about 50 body lengths per second, which would be comparable to a human running at 330 km/h (210 mph). It has a pair of large compound eyes, each having over 3,500 individual lenses (ommatidia, hexagonal apertures which provide a kind of vision known as mosaic vision, with more sensitivity but less resolution, particularly useful at night). It is a very active night insect that shuns light. American cockroach nymphs are capable of limb regeneration.
Annealing: This is a thermal treatment generally used to soften the material being drawn; to modify the microstructure, the mechanical properties, and the machining characteristics of the steel; and to remove internal stresses in the product. Depending on the material and desired final characteristics, annealing may be used before, during (between passes), or after the cold drawing operation.
Pot roast – in one of the Lakota legends recorded in Lakota mythology, the character Wohpe is seen creating a dish in exactly the same manner as we make pot roasts today—sealing a large chunk of meat and vegetables in a bag and steaming it in a pot.
Sources: en.wikipedia.org
A few teleosts are dangerous. Some, like eeltail catfish (Plotosidae), scorpionfish (Scorpaenidae) or stonefish (Synanceiidae) have venomous spines that can seriously injure or kill humans. Some, like the electric eel and the electric catfish, can give a severe electric shock. Others, such as the piranha and barracuda, have a powerful bite and have sometimes attacked human bathers. Reports indicate that some of the catfish family can be large enough to prey on human bathers. Medaka and zebrafish are used as research models for studies in genetics and developmental biology. The zebrafish is the most commonly used laboratory vertebrate, offering the advantages of genetic similarity to mammals, small size, simple environmental needs, transparent larvae permitting non-invasive imaging, plentiful offspring, rapid growth, and the ability to absorb mutagens added to their water.
== Personal life == In 1957, Marks married sculptor and artist Averil Sherrard and had two children. Marks was known to have been an atheist and a humanist who was opposed to religion. Along with his wife, he campaigned for various causes including saving a park in Guildford, Surrey, where they lived, from developers. He was a founding member of the charity HealthSense. His brother John Marks was also a doctor, and the chair of the British Medical Association. Marks died on 6 November 2023, at the age of 93.
Efforts to understand PQQ biosynthesis have contributed to broad interest in radical SAM enzymes and their ability to modify proteins, and an analogous radical SAM enzyme-dependent pathway has since been found that produces the putative electron carrier mycofactocin, using a valine and a tyrosine from the precursor peptide, MftA.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.